SKI Market

Indian Indices

Sensex

83,627.69 -250.48
( -0.30%)

Global Indices

Nasdaq

49,609.72 84.64
(0.17%)

Dow Jones

6,998.08 10.80
(0.15%)

Hang Seng

53,586.32 1,646.43
(3.17%)

Nikkei 225

10,138.60 -2.10
(-0.02%)

Forex

USD-INR

90.22 0.30
(0.34%)

EUR-INR

104.95 0.05
(0.04%)

GBP-INR

120.87 0.01
(0.01%)

JPY-INR

0.57 0.00
(-0.40%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Wanbury Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524212

INE107F01022

30.7353273

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

WANBURY

14.84

744.07

EPS(TTM)

Face Value()

Div & Yield %

14.37

Back

Suraj consolidated net profit declines 87.17% in the September 2025 quarter

Nov 10,2025

Net profit of Suraj declined 87.17% to Rs 0.83 crore in the quarter ended September 2025 as against Rs 6.47 crore during the previous quarter ended September 2024. Sales declined 11.39% to Rs 50.19 crore in the quarter ended September 2025 as against Rs 56.64 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	50.19	56.64	-11
OPM %	7.33	14.71	-
PBDT	4.35	11.02	-61
PBT	1.47	8.48	-83
NP	0.83	6.47	-87

83,627.69 -250.48 ( -0.30%)

49,609.72 84.64 (0.17%)

6,998.08 10.80 (0.15%)

53,586.32 1,646.43 (3.17%)

10,138.60 -2.10 (-0.02%)

90.22 0.30 (0.34%)

104.95 0.05 (0.04%)

120.87 0.01 (0.01%)

0.57 0.00 (-0.40%)